Loquinte, Char Janna M.
HRN: 27-06-17 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2025
CEFAZOLIN 1GM (VIAL)
05/30/2025
05/31/2025
IV
1 Gram
Q8 X 3 Doses
SP Repeat CS + BTL
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines